AstraZeneca tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.Market Watch • 08/03/26
Bristol Myers Squibb Stock Soars on Report of $400 Billion Merger Talks With AstraZenecaBarrons • 08/03/26
AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers SquibbCNBC • 08/03/26
AstraZeneca holds talks with Bristol Myers Squibb on potential megadeal, FT reportsReuters • 08/02/26
Bristol Myers Squibb Isn't Nearly as Cheap as It Looks -- Here's the 1 Thing That Could Change ThatThe Motley Fool • 08/01/26
Bristol Myers Squibb: Upgrading To Buy On Positive Q2 Earnings, Long-Term OutlookSeeking Alpha • 07/30/26
Bristol Myers (BMY) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 07/30/26
Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Beat EstimatesZacks Investment Research • 07/30/26